Clinical Trial Update: Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (IMPACT) is assessing whether combining isosorbide mononitrate with butylphthalide can reduce disability after acute lacunar stroke; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease
• Lacunar Stroke
• Stroke

Drugs mentioned

• Butylphthalide (butylphthalide)
• Isosorbide Mononitrate (isosorbide mononitrate)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke, Lacunar, Stroke, Acute Ischemic | Phase 3 | Status: NOT_YET_RECRUITING